| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Tim M. Illidge | Q37841680 |
| Dirk De Ruysscher | Q64584934 | ||
| P2093 | author name string | Shankar Siva | |
| Joe Y. Chang | |||
| Kobe Reynders | |||
| P2860 | cites work | Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: a case report | Q21198808 |
| Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated | Q28245528 | ||
| The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity | Q28304923 | ||
| Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy | Q29619961 | ||
| Immunogenic cell death in cancer therapy | Q29620118 | ||
| Immunologic correlates of the abscopal effect in a patient with melanoma | Q29620334 | ||
| Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. | Q33930593 | ||
| Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis | Q34067939 | ||
| γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo | Q34091374 | ||
| Immunogenic cell death and DAMPs in cancer therapy | Q34311701 | ||
| Radiation Enhances Regulatory T Cell Representation | Q35053414 | ||
| Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab | Q35289145 | ||
| Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy | Q35540109 | ||
| Spontaneous regression of hepatocellular carcinoma: a case report and literature review | Q35746526 | ||
| Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response | Q36120970 | ||
| Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review). | Q36142682 | ||
| The convergence of radiation and immunogenic cell death signaling pathways. | Q36144356 | ||
| The abscopal effect associated with a systemic anti-melanoma immune response | Q36153077 | ||
| Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma | Q36380424 | ||
| Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody | Q37351567 | ||
| Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. | Q37524200 | ||
| Systemic effects of local radiotherapy | Q37539309 | ||
| Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells | Q37620420 | ||
| Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing | Q37660302 | ||
| Spontaneous regression of thoracic malignancies | Q37767939 | ||
| Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). | Q37974257 | ||
| Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. | Q38233743 | ||
| Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy | Q38974149 | ||
| Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status | Q39042161 | ||
| Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer | Q39569395 | ||
| Radiation induces an antitumour immune response to mouse melanoma | Q39765745 | ||
| Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature | Q40351199 | ||
| The abscopal effect and chronic lymphocytic leukemia | Q40602275 | ||
| Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas | Q41237590 | ||
| An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. | Q41790713 | ||
| Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report | Q42062177 | ||
| A systemic complete response of metastatic melanoma to local radiation and immunotherapy. | Q42701258 | ||
| Trial Watch: Anticancer radioimmunotherapy | Q42847992 | ||
| Atypical clinical response patterns to ipilimumab | Q45216216 | ||
| Radiation abscopal antitumor effect is mediated through p53 | Q47965289 | ||
| Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: abscopal effect prevented by the blood-brain barrier? | Q48618995 | ||
| Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. | Q50777923 | ||
| Abscopal effect on hepatocellular carcinoma. | Q53417218 | ||
| Spontaneous regression of a large hepatocellular carcinoma with skull metastasis. | Q53625788 | ||
| Abscopal effect of radiation in papillary adenocarcinoma. | Q54301369 | ||
| Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer | Q56903097 | ||
| Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis | Q57650427 | ||
| Abscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung Cancer | Q57758819 | ||
| An interesting case of possible abscopal effect in malignant melanoma | Q67513908 | ||
| Abscopal regression in lymphoma: a mechanism in common with total body irradiation? | Q70823779 | ||
| Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumour | Q71666994 | ||
| The Abscopal Effect in Malignant Lymphoma and Its Relationship to Lymphocyte Circulation | Q72535440 | ||
| Abscopal regression following radiotherapy for adenocarcinoma | Q72686262 | ||
| Whole body irradiation; radiobiology or medicine? | Q73123026 | ||
| Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer | Q73336669 | ||
| Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy | Q73496463 | ||
| Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer | Q77357816 | ||
| Flt3L therapy following localized tumor irradiation generates long-term protective immune response in metastatic lung cancer: its implication in designing a vaccination strategy | Q79261111 | ||
| Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration | Q79370218 | ||
| Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma--a case report | Q79911195 | ||
| Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha | Q80723472 | ||
| Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice | Q80727108 | ||
| Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma | Q83946224 | ||
| Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity | Q84570464 | ||
| Tumour necrosis factor and cancer | Q86271551 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 503-10 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Cancer Treatment Reviews | Q1955762 |
| P1476 | title | The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant | |
| P478 | volume | 41 |
| Q42371795 | A Case of Complete Abscopal Response in High-Grade Pleiomorphic Sarcoma Treated with Radiotherapy Alone |
| Q89647107 | A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups |
| Q39342652 | A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma |
| Q28079625 | A critical review of recent developments in radiotherapy for non-small cell lung cancer |
| Q36286199 | A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger? |
| Q38679488 | A perspective on the impact of radiation therapy on the immune rheostat |
| Q37665688 | A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma |
| Q51737731 | A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma. |
| Q36651935 | A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II) |
| Q90734665 | Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma |
| Q58566337 | Abscopal Effect after Palliative Radiation Therapy for Metastatic Adenocarcinoma of the Esophagus |
| Q92257036 | Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer |
| Q64262451 | Abscopal Effect of Radiotherapy in Imatinib-resistant Dermatofibrosarcoma Protuberans |
| Q64262336 | Abscopal Effect, From Myth to Reality: From Radiation Oncologists' Perspective |
| Q92478240 | Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| Q42222358 | Abscopal Effects: Case Report and Emerging Opportunities |
| Q49553757 | Abscopal effect of radiation on bone metastases of breast cancer: A case report |
| Q64065806 | Abscopal effect of radiation on multiple lung metastases of lung adenocarcinoma: a case report |
| Q58773898 | Abscopal effect of radiotherapy combined with immune checkpoint inhibitors |
| Q52968091 | Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor. |
| Q48238878 | Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model. |
| Q47899811 | Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. |
| Q99634737 | Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching |
| Q91892155 | Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation |
| Q60934382 | Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response |
| Q41988203 | An abscopal effect in a case of concomitant treatment of locally and peritoneally recurrent gastric cancer using adoptive T-cell immunotherapy and radiotherapy |
| Q98944861 | An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma |
| Q41930681 | Antigen Cross-Presentation and T-Cell Cross-Priming In Cancer Immunology And Immunotherapy |
| Q92757487 | Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences |
| Q64885683 | Bioengineering of Metal-organic Frameworks for Nanomedicine. |
| Q92016859 | Bystander effects of ionizing radiation: conditioned media from X-ray irradiated MCF-7 cells increases the angiogenic ability of endothelial cells |
| Q94547379 | Cancer Radiotherapy: Understanding the Price of Tumor Eradication |
| Q61813707 | Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma |
| Q64271553 | Chemoradiotherapy-Induced CD4 and CD8 T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma |
| Q90468289 | Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma |
| Q60922811 | Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle |
| Q90706021 | Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy |
| Q52718920 | Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer? |
| Q52597555 | Combination therapy with PD-1/PD-L1 blockade: An overview of ongoing clinical trials. |
| Q38645128 | Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization. |
| Q33645601 | Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors |
| Q90197706 | Combining immunotherapy and radiotherapy for the STAR treatment |
| Q38679418 | Combining radiotherapy with immunotherapy: the past, the present and the future |
| Q61804646 | Combining stereotactic body radiation therapy with immunotherapy: current data and future directions |
| Q91741550 | Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines |
| Q56889583 | Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma |
| Q89694191 | Cross Talk between Radiation and Immunotherapy: The Twain Shall Meet |
| Q89811416 | Current approaches to the management of brain metastases |
| Q49815979 | Decreased Survival After Combining Thoracic Irradiation and an Anti-PD-1 Antibody Correlated With Increased T-cell Infiltration Into Cardiac and Lung Tissues |
| Q37716378 | Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic |
| Q47974790 | Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study |
| Q46311025 | Effect of intra-tumoral magnetic nanoparticle hyperthermia and viral nanoparticle immunogenicity on primary and metastatic cancer |
| Q40403996 | Elective nodal irradiation is not necessary in chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer. |
| Q38809772 | Emerging Opportunities and Challenges in Cancer Immunotherapy. |
| Q92578264 | Engineering patient-specific cancer immunotherapies |
| Q100386707 | Enhancing the efficacy of immunotherapy using radiotherapy |
| Q64990381 | Evidence for surgical resections in oligometastatic lung cancer. |
| Q64080822 | Exceptional antitumor responses beyond immune checkpoint inhibition in non-small cell lung cancer patients: insights into optimal therapy sequencing |
| Q64086941 | Exosomes in esophageal cancer: A review on tumorigenesis, diagnosis and therapeutic potential |
| Q89017219 | FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients |
| Q36356635 | Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously |
| Q64248736 | From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC |
| Q58119207 | Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation |
| Q91798966 | Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response |
| Q38806243 | Harnessing the immune system for the treatment of melanoma: current status and future prospects. |
| Q89429146 | High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma |
| Q47331772 | Hypo-fractionated Radiation, Magnetic Nanoparticle Hyperthermia and a Viral Immunotherapy Treatment of Spontaneous Canine Cancer |
| Q55304421 | Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality? |
| Q41167610 | Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. |
| Q64238292 | Immune targets in the tumor microenvironment treated by radiotherapy |
| Q30354580 | Immunological effect of local ablation combined with immunotherapy on solid malignancies. |
| Q92736066 | Immunotherapeutic Transport Oncophysics: Space, Time, and Immune Activation in Cancer |
| Q38632924 | Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection |
| Q33645624 | Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer |
| Q92626003 | Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches |
| Q54978827 | Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages? |
| Q60931068 | Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment |
| Q94465299 | Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer |
| Q89967050 | Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients |
| Q50731156 | Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab. |
| Q55106579 | In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series. |
| Q49571153 | Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop |
| Q90007129 | Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer |
| Q38749802 | Irradiation and immunotherapy: From concept to the clinic |
| Q55513615 | Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma. |
| Q26766238 | Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors |
| Q55286402 | Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance? |
| Q64094854 | Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation |
| Q90254034 | Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy |
| Q50125923 | Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges. |
| Q38901163 | Metastatic breast cancer: The Odyssey of personalization |
| Q37622998 | Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report |
| Q47718948 | Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study. |
| Q52714591 | Molecular mechanism of bystander effects and related abscopal/cohort effects in cancer therapy. |
| Q45068305 | Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases |
| Q90039977 | Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies |
| Q55233806 | Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy. |
| Q94355088 | Neoadjuvant treatment for malignant and metastatic cutaneous melanoma |
| Q26740988 | New targeted treatments for non-small-cell lung cancer - role of nivolumab |
| Q61807609 | Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects |
| Q50484415 | Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study. |
| Q52888621 | Optimizing Radiotherapy with Immunotherapeutic Approaches. |
| Q54974804 | Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study. |
| Q89832045 | Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy |
| Q58729482 | Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance |
| Q91713549 | Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients |
| Q26771870 | Predictors of clinical response to immunotherapy with or without radiotherapy |
| Q60959934 | Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect? |
| Q96134636 | Radiation Exposure-Induced Changes in the Immune Cells and Immune Factors of Mice With or Without Primary Lung Tumor |
| Q90699465 | Radiation Therapy as a Modality to Create Abscopal Effects: Current and Future Practices |
| Q47703452 | Radiation effects on antitumor immune responses: current perspectives and challenges |
| Q47098450 | Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report |
| Q57161810 | Radiation, inflammation and the immune response in cancer |
| Q96683847 | Radiation-induced bystander and abscopal effects: important lessons from preclinical models |
| Q53804152 | Radical treatment of synchronous oligometastases from NSCLC. |
| Q88168805 | Radiotherapy and PD-L1 inhibition in metastatic NSCLC |
| Q60954603 | Radiotherapy as a New Player in Immuno-Oncology |
| Q39385461 | Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach |
| Q64927862 | Radiotherapy in Combination With Cytokine Treatment. |
| Q95406381 | Radiotherapy toxicity |
| Q52602002 | Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy. |
| Q37351338 | Radiotherapy: Changing the Game in Immunotherapy. |
| Q90811958 | Radiothérapie et immunothérapie |
| Q38981347 | Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment |
| Q38648236 | Realistic biological approaches for improving thermoradiotherapy. |
| Q92876161 | Relevance of Non-Targeted Effects for Radiotherapy and Diagnostic Radiology; A Historical and Conceptual Analysis of Key Players |
| Q91148338 | Renewed interest for low-dose radiation therapy in follicular lymphomas: From biology to clinical applications |
| Q54967636 | Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer. |
| Q98157769 | SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges |
| Q58743563 | SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases |
| Q55342016 | SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. |
| Q61816938 | Selected Office Based Anticancer Treatment Strategies |
| Q39208496 | Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors |
| Q92977319 | Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy |
| Q57581058 | Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy |
| Q54942435 | Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions. |
| Q50898681 | Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. |
| Q38828265 | Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy? |
| Q55129503 | Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer. |
| Q37277324 | Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer. |
| Q64071654 | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy |
| Q52690007 | The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity? |
| Q38875105 | The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer? |
| Q55038014 | The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent. |
| Q54942438 | The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. |
| Q92715618 | The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond |
| Q52808480 | The effect of hypofractionated radiation and magnetic nanoparticle hyperthermia on tumor immunogenicity and overall treatment response. |
| Q54239507 | The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy. |
| Q59469171 | The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer. |
| Q64977994 | Translational research in radiation-induced DNA damage signaling and repair. |
| Q90141223 | Tumor-derived extracellular vesicles: insights into bystander effects of exosomes after irradiation |
| Q50544077 | Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo. |
| Q40070538 | Tumour radiosensitivity is associated with immune activation in solid tumours |
| Q37584420 | Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature |
Search more.